Drug derived from Caribbean reefs may treat psoriasis, MS | Fox News: A biotechnology company developing an unusual drug—derived from the venom of a sea anemone to treat autoimmune diseases such as psoriasis and multiple sclerosis—reported encouraging results from a phase 1 clinical trial.
No comments:
Post a Comment